
Choice Made Simple!
Too many options?Click below to purchase an online gift card that can be used at participating retailers in Village Green Shopping Centre and continue your shopping IN CENTRE!Purchase HereHome
Fenbendazole and Ivermectin Mebendazole Protocols: An Evidence-Based Guide for Patients, Caregivers, and Clinicians
Coles
Loading Inventory...
Fenbendazole and Ivermectin Mebendazole Protocols: An Evidence-Based Guide for Patients, Caregivers, and Clinicians in Vernon, BC
By None
Current price: $12.99

Coles
Fenbendazole and Ivermectin Mebendazole Protocols: An Evidence-Based Guide for Patients, Caregivers, and Clinicians in Vernon, BC
By None
Current price: $12.99
Loading Inventory...
Size: Kobo eBook
*Product information may vary - to confirm product availability, pricing, shipping and return information please contact Coles
Are the answers to our most complex medical challenges hiding in plain sight?
In the rapidly evolving landscape of modern oncology, a "repurposing revolution" is taking place. Fenbendazole and Ivermectin Mebendazole Protocols is a comprehensive exploration of how low-cost, off-label anti-parasitic medications are being investigated to fight aggressive and treatment-resistant cancers.
Written by journalist and patient advocate Donald Lundeen, this guide bridges the gap between anecdotal "miracle cures" and rigorous scientific inquiry. Rather than a DIY manual, this book provides a "hopeful realism" for those who feel they have reached the end of the conventional medical road.
Inside This Groundbreaking Guide:
The Science of Repurposing: Discover how drugs once meant for parasites target the "Hallmarks of Cancer" by disrupting cellular skeletons, starving tumors of glucose, and inhibiting cancer stem cells.
Fenbendazole (The Accidental Pioneer): A deep dive into the "Joe Tippens Protocol" and the preclinical evidence showing how this veterinary dewormer may sensitize tumors to radiation and chemotherapy.
Ivermectin (Beyond the Controversy): Moving past the headlines to explore this Nobel Prize-winning drug's ability to reverse multidrug resistance and "unmask" cancer cells to the immune system.
Mebendazole (The Quiet Contender): An analysis of the human-grade benzimidazole with promising clinical trial data for brain tumors (Glioblastoma) and its ability to cross the blood-brain barrier.
The Integrative Approach: Practical advice on combining these protocols with standard oncology care, including the critical importance of timing, sequencing, and avoiding drug interactions.
Safety & Sourcing: A "Safety First" guide to monitoring liver enzymes and blood counts, deconstructing the risks of veterinary-grade vs. pharmaceutical-grade sourcing.
Empower Your Journey
This book is a vital resource for patients seeking agency, caregivers acting as advocates, and clinicians open to the future of integrative cancer care. It provides the vocabulary and scientific foundation to transform a daunting diagnosis into a collaborative search for answers.
Take control of your health with evidence, not just hope.
About the Author
Donald Lundeen is a journalist and advocate for patient empowerment. Driven by the stories of "citizen scientists" and a conviction that knowledge is power, he serves as a bridge between complex laboratory research and the patients who need it most.
Are the answers to our most complex medical challenges hiding in plain sight?
In the rapidly evolving landscape of modern oncology, a "repurposing revolution" is taking place. Fenbendazole and Ivermectin Mebendazole Protocols is a comprehensive exploration of how low-cost, off-label anti-parasitic medications are being investigated to fight aggressive and treatment-resistant cancers.
Written by journalist and patient advocate Donald Lundeen, this guide bridges the gap between anecdotal "miracle cures" and rigorous scientific inquiry. Rather than a DIY manual, this book provides a "hopeful realism" for those who feel they have reached the end of the conventional medical road.
Inside This Groundbreaking Guide:
The Science of Repurposing: Discover how drugs once meant for parasites target the "Hallmarks of Cancer" by disrupting cellular skeletons, starving tumors of glucose, and inhibiting cancer stem cells.
Fenbendazole (The Accidental Pioneer): A deep dive into the "Joe Tippens Protocol" and the preclinical evidence showing how this veterinary dewormer may sensitize tumors to radiation and chemotherapy.
Ivermectin (Beyond the Controversy): Moving past the headlines to explore this Nobel Prize-winning drug's ability to reverse multidrug resistance and "unmask" cancer cells to the immune system.
Mebendazole (The Quiet Contender): An analysis of the human-grade benzimidazole with promising clinical trial data for brain tumors (Glioblastoma) and its ability to cross the blood-brain barrier.
The Integrative Approach: Practical advice on combining these protocols with standard oncology care, including the critical importance of timing, sequencing, and avoiding drug interactions.
Safety & Sourcing: A "Safety First" guide to monitoring liver enzymes and blood counts, deconstructing the risks of veterinary-grade vs. pharmaceutical-grade sourcing.
Empower Your Journey
This book is a vital resource for patients seeking agency, caregivers acting as advocates, and clinicians open to the future of integrative cancer care. It provides the vocabulary and scientific foundation to transform a daunting diagnosis into a collaborative search for answers.
Take control of your health with evidence, not just hope.
About the Author
Donald Lundeen is a journalist and advocate for patient empowerment. Driven by the stories of "citizen scientists" and a conviction that knowledge is power, he serves as a bridge between complex laboratory research and the patients who need it most.


















